KEGG   PATHWAY: shon05200
Entry
shon05200                   Pathway                                
Name
Pathways in cancer - Sturnira hondurensis
Class
Human Diseases; Cancer: overview
Pathway map
shon05200  Pathways in cancer
shon05200

Organism
Sturnira hondurensis [GN:shon]
Gene
118978779  netrin receptor DCC [KO:K06765]
118993073  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
118986319  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
118983367  APPL1; DCC-interacting protein 13-alpha isoform X1 [KO:K08733]
118983812  CDH1; cadherin-1 [KO:K05689]
118976240  CTNNB1; catenin beta-1 [KO:K02105]
118997606  CTNNA1; catenin alpha-1 [KO:K05691]
118982521  catenin alpha-2 [KO:K05691]
118998485  CTNNA3; catenin alpha-3 [KO:K05691]
119000346  catenin alpha-2-like [KO:K05691]
118978824  AXIN1; axin-1 isoform X1 [KO:K02157]
119003507  AXIN2; axin-2 isoform X1 [KO:K04385]
118984418  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
118977277  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
118986594  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
118990084  TCF7; transcription factor 7 isoform X1 [KO:K02620]
118989528  LOW QUALITY PROTEIN: transcription factor 7-like 1 [KO:K04490]
118982463  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
118999410  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
118977082  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
118999731  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
118988677  MYC; myc proto-oncogene protein isoform X1 [KO:K04377]
118998396  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
118976390  WNT1; proto-oncogene Wnt-1 [KO:K03209]
118981958  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
118999582  WNT2; protein Wnt-2 [KO:K00182]
118982918  WNT3A; protein Wnt-3a [KO:K00312]
119003572  WNT3; proto-oncogene Wnt-3 [KO:K00312]
118977789  WNT4; protein Wnt-4 [KO:K00408]
118983356  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
118999993  WNT5B; protein Wnt-5b [KO:K00444]
118975399  WNT6; protein Wnt-6 [KO:K00445]
118980903  WNT7A; protein Wnt-7a [KO:K00572]
118989373  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
118998773  WNT8A; protein Wnt-8a isoform X1 [KO:K00714]
118999514  WNT8B; protein Wnt-8b [KO:K00714]
118982917  WNT9A; protein Wnt-9a isoform X1 [KO:K01064]
119003661  WNT9B; protein Wnt-9b [KO:K01064]
118975384  WNT10A; protein Wnt-10a [KO:K01357]
118976497  WNT10B; protein Wnt-10b [KO:K01357]
118981616  WNT11; protein Wnt-11 [KO:K01384]
118994004  WNT16; protein Wnt-16 [KO:K01558]
119000959  FZD1; frizzled-1 [KO:K02432]
118985227  FZD7; frizzled-7 [KO:K02432]
119001926  FZD2; frizzled-2 [KO:K02235]
118984344  FZD3; frizzled-3 [KO:K02329]
118984749  FZD4; frizzled-4 isoform X1 [KO:K02354]
118981065  FZD8; frizzled-8 [KO:K02375]
118985177  FZD5; frizzled-5 [KO:K02375]
118988582  FZD6; frizzled-6 isoform X1 [KO:K02376]
118990997  FZD10; frizzled-10 [KO:K02842]
118992806  FZD9; frizzled-9 [KO:K02842]
118998387  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
118978366  LRP6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
118974282  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
118974684  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
118998196  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
118990288  FRAT1; proto-oncogene FRAT1 [KO:K03069]
118990287  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
118974544  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
118996691  AGT; angiotensinogen [KO:K09821]
118977327  F2R; proteinase-activated receptor 1 [KO:K03914]
118975206  F2RL3; proteinase-activated receptor 4 [KO:K04236]
118979710  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]
118975067  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
118997361  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]
118996752  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
119002175  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
118983991  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
118997940  AGTR1; type-1 angiotensin II receptor [KO:K04166]
118995031  GNA12; guanine nucleotide-binding protein subunit alpha-12 [KO:K04346]
119003776  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
118974946  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
119000475  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
118998137  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
118989480  RHOA; transforming protein RhoA [KO:K04513]
118976915  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
118988767  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
118979932  CXCL12; stromal cell-derived factor 1 isoform X1 [KO:K10031]
118974799  CXCR4; C-X-C chemokine receptor type 4 [KO:K04189]
118989455  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
118990034  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
119000994  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
118984077  prostaglandin E2 receptor EP1 subtype isoform X1 [KO:K04258]
118992398  PTGER2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
118984469  PTGER3; prostaglandin E2 receptor EP3 subtype isoform X1 [KO:K04260]
118998799  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
118996538  guanine nucleotide-binding protein G(s) subunit alpha-like isoform X1 [KO:K04632]
118996540  neuroendocrine secretory protein 55-like [KO:K04632]
118983483  ADCY1; adenylate cyclase type 1 isoform X1 [KO:K08041] [EC:4.6.1.1]
118998674  ADCY2; adenylate cyclase type 2 isoform X1 [KO:K08042] [EC:4.6.1.1]
119001392  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
118980863  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
118990736  ADCY5; adenylate cyclase type 5 isoform X1 [KO:K08045] [EC:4.6.1.1]
118976509  ADCY6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
119001137  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
118988683  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
118975805  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
118997372  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
118984085  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
118998185  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
118992860  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
119002185  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
118995666  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
118992638  GNB5; guanine nucleotide-binding protein subunit beta-5 isoform X1 [KO:K04539]
118992392  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
118991623  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
118980656  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
118997366  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
119001978  LOW QUALITY PROTEIN: guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5-like [KO:K04542]
118984459  GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
118995956  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
118979604  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
118980212  LOW QUALITY PROTEIN: guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11-like [KO:K04546]
118987353  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
118984142  GNG14; putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 isoform X1 [KO:K04347]
118984613  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
118978877  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
118987352  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
118978071  GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
118981561  COL4A2; collagen alpha-2(IV) chain [KO:K06237]
118981562  COL4A1; collagen alpha-1(IV) chain isoform X1 [KO:K06237]
118975371  COL4A4; collagen alpha-4(IV) chain isoform X1 [KO:K06237]
118975373  COL4A3; collagen alpha-3(IV) chain [KO:K06237]
118984177  COL4A5; collagen alpha-5(IV) chain [KO:K06237]
118989974  LAMA1; laminin subunit alpha-1 isoform X1 [KO:K05637]
118986712  LAMA2; laminin subunit alpha-2 isoform X1 [KO:K05637]
118996567  LAMA5; laminin subunit alpha-5 isoform X1 [KO:K06240]
118977209  LAMA3; laminin subunit alpha-3 isoform X1 [KO:K06240]
119000190  LAMA4; laminin subunit alpha-4 isoform X1 [KO:K06241]
119003970  LAMB1; laminin subunit beta-1 [KO:K05636]
118989487  LAMB2; laminin subunit beta-2 isoform X1 [KO:K06243]
119004259  LAMB3; laminin subunit beta-3 [KO:K06244]
119003986  LAMB4; laminin subunit beta-4 isoform X1 [KO:K06245]
118979279  LAMC1; laminin subunit gamma-1 [KO:K05635]
118979115  LAMC2; laminin subunit gamma-2 [KO:K06246]
118980200  LAMC3; laminin subunit gamma-3 [KO:K06247]
118981671  ITGA2; integrin alpha-2 isoform X1 [KO:K06481]
119001963  ITGA2B; integrin alpha-IIb [KO:K06476]
118978022  ITGA3; integrin alpha-3 [KO:K06482]
118985704  ITGA6; integrin alpha-6 isoform X1 [KO:K06485]
118985328  ITGAV; integrin alpha-V isoform X1 [KO:K06487]
118991564  integrin beta-1 [KO:K05719]
118988708  PTK2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
118997522  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
118986375  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
118995662  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
118982454  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
118975178  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
118998595  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
118988011  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
118975140  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
118988441  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
119003271  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
118988089  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
118999523  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
118993207  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
118994325  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
118993928  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
118979949  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
118999475  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
118991736  RELA; transcription factor p65 [KO:K04735]
118979157  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
119003495  NOS2; LOW QUALITY PROTEIN: nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
118979386  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
118975660  BIRC2; baculoviral IAP repeat-containing protein 2 [KO:K16060]
118975664  baculoviral IAP repeat-containing protein 3-like [KO:K16060]
119001606  E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
118996583  BIRC7; baculoviral IAP repeat-containing protein 7 isoform X1 [KO:K16061]
118985337  BCL2L1; bcl-2-like protein 1 [KO:K04570]
118995980  TRAF1; TNF receptor-associated factor 1 [KO:K03172]
118980132  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
118976597  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
119003465  TRAF4; TNF receptor-associated factor 4 [KO:K09848]
119004242  TRAF5; TNF receptor-associated factor 5 isoform X1 [KO:K09849]
118983180  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
118986352  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
118991818  RPS6KB2; ribosomal protein S6 kinase beta-2 [KO:K04688] [EC:2.7.11.1]
119003484  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
118991674  BAD; bcl2-associated agonist of cell death isoform X1 [KO:K02158]
118994827  FOXO1; forkhead box protein O1 [KO:K07201]
118989366  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
118974748  TP53; cellular tumor antigen p53 [KO:K04451]
118978371  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
118998962  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
119001900  BCR; breakpoint cluster region protein [KO:K08878] [EC:2.7.11.1]
118980343  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
119001789  CRKL; crk-like protein [KO:K04438]
119003414  CRK; adapter molecule crk isoform X1 [KO:K04438]
119001927  CBL; E3 ubiquitin-protein ligase CBL isoform X1 [KO:K04707] [EC:2.3.2.27]
118978082  signal transducer and activator of transcription 5A [KO:K11223]
118977990  signal transducer and activator of transcription 5B [KO:K11224]
118998952  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
118998330  PIM2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
118983148  KNG1; kininogen-1 [KO:K03898]
118981239  EDN1; endothelin-1 [KO:K16366]
118976635  BDKRB1; B1 bradykinin receptor [KO:K03915]
118976804  BDKRB2; B2 bradykinin receptor isoform X1 [KO:K03916]
118995415  EDNRA; endothelin-1 receptor [KO:K04197]
118996129  EDNRB; endothelin receptor type B [KO:K04198]
118976055  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
118984473  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
118990867  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
118990869  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
118991671  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
118993594  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 [KO:K05858] [EC:3.1.4.11]
119003729  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
119004000  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
118986634  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
118995277  IL2; interleukin-2 [KO:K05429]
118990129  IL4; interleukin-4 [KO:K05430]
118990131  IL5; LOW QUALITY PROTEIN: interleukin-5 [KO:K05428]
118997775  IL7; interleukin-7 isoform X1 [KO:K05431]
118987454  IL12A; interleukin-12 subunit alpha [KO:K05406]
118984138  IL12B; interleukin-12 subunit beta [KO:K05425]
118990130  IL13; interleukin-13 [KO:K05435]
118995438  IL15; interleukin-15 [KO:K05433]
118976004  IL23A; interleukin-23 subunit alpha [KO:K05426]
118992858  EPO; erythropoietin [KO:K05437]
118997983  interferon alpha-2-like [KO:K05414]
118984066  interferon alpha-4-like [KO:K05414]
118978917  interferon alpha-2-like [KO:K05414]
118989641  IFNG; interferon gamma [KO:K04687]
119000807  IL2RA; interleukin-2 receptor subunit alpha isoform X1 [KO:K05068]
119002352  IL2RB; interleukin-2 receptor subunit beta [KO:K05069]
118974342  IL3RA; interleukin-3 receptor subunit alpha [KO:K04737]
119001758  IL4R; interleukin-4 receptor subunit alpha isoform X1 [KO:K05071]
119002296  CSF2RB; cytokine receptor common subunit beta isoform X1 [KO:K04738]
118989401  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
118990189  IL6R; interleukin-6 receptor subunit alpha isoform X1 [KO:K05055]
118981655  IL6ST; interleukin-6 receptor subunit beta [KO:K05060]
118998771  IL7R; interleukin-7 receptor subunit alpha [KO:K05072]
118975125  IL12RB1; interleukin-12 receptor subunit beta-1 isoform X1 [KO:K05063]
118984685  IL12RB2; interleukin-12 receptor subunit beta-2 isoform X1 [KO:K05064]
118989853  IL13RA1; interleukin-13 receptor subunit alpha-1 isoform X1 [KO:K05076]
119000806  IL15RA; interleukin-15 receptor subunit alpha isoform X1 [KO:K05074]
118985593  IL23R; interleukin-23 receptor [KO:K05065]
119000288  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
119000285  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
118986670  IFNGR1; interferon gamma receptor 1 isoform X1 [KO:K05132]
119000289  IFNGR2; interferon gamma receptor 2 [KO:K05133]
119001215  EML4; LOW QUALITY PROTEIN: echinoderm microtubule-associated protein-like 4 [KO:K15420]
119001399  ALK tyrosine kinase receptor-like [KO:K05119] [EC:2.7.10.1]
118993611  RASGRP1; RAS guanyl-releasing protein 1 [KO:K04350]
118991686  RASGRP2; RAS guanyl-releasing protein 2 isoform X1 [KO:K12361]
119001280  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
118976320  RASGRP4; RAS guanyl-releasing protein 4 [KO:K12363]
118985040  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
118975019  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
118978208  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
118985299  STAT1; signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220]
118975851  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
118985298  STAT4; signal transducer and activator of transcription 4 [KO:K11222]
118975844  STAT6; signal transducer and activator of transcription 6 isoform X1 [KO:K11225]
118993927  VEGFA; vascular endothelial growth factor A [KO:K05448]
118991667  VEGFB; vascular endothelial growth factor B isoform X1 [KO:K16858]
118976883  PGF; placenta growth factor isoform X1 [KO:K16859]
118993053  VEGFC; vascular endothelial growth factor C [KO:K05449]
118987248  VEGFD; vascular endothelial growth factor D isoform X1 [KO:K05449]
118988493  TGFA; protransforming growth factor alpha [KO:K08774]
118977074  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
118983507  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
118978214  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
118995064  PDGFA; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
119002339  PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386]
118978642  PDGFRA; platelet-derived growth factor receptor alpha isoform X1 [KO:K04363] [EC:2.7.10.1]
118986157  PDGFRB; platelet-derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
119002367  IGF1; insulin-like growth factor I isoform X1 [KO:K05459]
118988333  IGF2; insulin-like growth factor II isoform X1 [KO:K13769]
118992013  IGF1R; insulin-like growth factor 1 receptor isoform X1 [KO:K05087] [EC:2.7.10.1]
118999914  KITLG; kit ligand isoform X1 [KO:K05461]
118978582  KIT; mast/stem cell growth factor receptor Kit isoform X1 [KO:K05091] [EC:2.7.10.1]
118995806  FLT3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
119000987  HGF; hepatocyte growth factor isoform X1 [KO:K05460]
118998653  FGF1; fibroblast growth factor 1 [KO:K18496]
118995576  FGF2; LOW QUALITY PROTEIN: fibroblast growth factor 2 [KO:K18497]
118980540  FGF9; fibroblast growth factor 9 [KO:K04358]
118996740  FGF16; fibroblast growth factor 16 [KO:K04358]
118981674  FGF10; fibroblast growth factor 10 [KO:K04358]
118990454  FGF5; fibroblast growth factor 5 [KO:K04358]
118998373  FGF4; fibroblast growth factor 4 [KO:K04358]
118998410  FGF3; fibroblast growth factor 3 [KO:K04358]
118975163  FGF17; fibroblast growth factor 17 isoform X1 [KO:K04358]
118999542  FGF8; fibroblast growth factor 8 isoform X1 [KO:K04358]
119000021  FGF6; fibroblast growth factor 6 [KO:K04358]
118984625  FGF22; LOW QUALITY PROTEIN: fibroblast growth factor 22 [KO:K04358]
118992607  FGF7; fibroblast growth factor 7 [KO:K04358]
118992994  FGF20; fibroblast growth factor 20 [KO:K04358]
118994948  FGF18; fibroblast growth factor 18 [KO:K04358]
118998372  FGF19; fibroblast growth factor 19 [KO:K22603]
118999897  FGF23; fibroblast growth factor 23 [KO:K22428]
118993177  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
118996291  FGFR2; fibroblast growth factor receptor 2 isoform X1 [KO:K05093] [EC:2.7.10.1]
118987768  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
118999740  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
119000762  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
118992372  SOS2; son of sevenless homolog 2 [KO:K03099]
119001478  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
118982230  HRAS; GTPase HRas isoform X1 [KO:K02833]
118978497  KRAS; GTPase KRas isoform X1 [KO:K07827]
118981977  NRAS; GTPase NRas [KO:K07828]
118998301  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
118989073  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
118990300  RAF1; RAF proto-oncogene serine/threonine-protein kinase [KO:K04366] [EC:2.7.11.1]
118992336  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
118984505  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
119000423  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
119001903  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
118984936  JUN; transcription factor AP-1 [KO:K04448]
118976823  FOS; proto-oncogene c-Fos [KO:K04379]
118981504  ETS1; protein C-ets-1 isoform X1 [KO:K02678]
118975722  MMP1; interstitial collagenase [KO:K01388] [EC:3.4.24.7]
119001111  MMP2; 72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
118985553  MMP9; matrix metalloproteinase-9 isoform X1 [KO:K01403] [EC:3.4.24.35]
118999083  C-X-C motif chemokine 15-like isoform X1 [KO:K10030]
118999088  CXCL8; interleukin-8 [KO:K10030]
118975891  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
118976567  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
118981054  RET; proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 [KO:K05126] [EC:2.7.10.1]
118998508  CCDC6; coiled-coil domain-containing protein 6 isoform X1 [KO:K09288]
118994134  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
118990194  TPM3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
118979049  TPR; nucleoprotein TPR isoform X1 [KO:K09291]
118995839  TFG; protein TFG isoform X1 [KO:K09292]
118989445  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
119001649  RASSF5; ras association domain-containing protein 5 isoform X1 [KO:K08015]
118985521  STK4; serine/threonine-protein kinase 4 [KO:K04411]
118984501  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
118992293  DAPK2; death-associated protein kinase 2 isoform X1 [KO:K08803] [EC:2.7.11.1]
118979840  DAPK1; death-associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]
118985484  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
118983037  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
118998304  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
118990028  calmodulin-1 [KO:K02183]
118998106  CALML6; calmodulin-like protein 6 [KO:K02183]
118999921  calmodulin-alpha-like [KO:K02183]
118976572  CALM1; calmodulin-1 [KO:K02183]
118992351  CALML4; LOW QUALITY PROTEIN: calmodulin-like protein 4 [KO:K02183]
119000796  calmodulin-A-like [KO:K02183]
119000797  CALML3; calmodulin-like protein 3 [KO:K02183]
119001010  calmodulin-2/4 [KO:K02183]
119001255  CALM2; calmodulin-2 [KO:K02183]
118995942  CALM3; calmodulin-3 [KO:K02183]
118983461  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
118986155  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
118993496  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
118980016  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
118980105  RALGDS; ral guanine nucleotide dissociation stimulator isoform X1 [KO:K08732]
119001847  ras-related protein Ral-A-like [KO:K07834]
118994012  RALA; ras-related protein Ral-A [KO:K07834]
118989536  RALB; ras-related protein Ral-B [KO:K07835]
118989987  RALBP1; ralA-binding protein 1 isoform X1 [KO:K08773]
118977719  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
118995001  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
119002327  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
119002854  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
119001060  PLD2; phospholipase D2 isoform X1 [KO:K01115] [EC:3.1.4.4]
118987399  PLD1; phospholipase D1 isoform X1 [KO:K01115] [EC:3.1.4.4]
118976281  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
118994117  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
118995102  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
118981929  PAX8; paired box protein Pax-8 isoform X1 [KO:K09293]
118990275  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
118980369  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
118991475  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
118979266  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
119004030  RARB; retinoic acid receptor beta isoform X1 [KO:K08528]
118990270  ESR1; estrogen receptor [KO:K08550]
118976878  ESR2; estrogen receptor beta [KO:K08551]
119001390  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
118985573  NCOA3; nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
118991527  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
118978065  junction plakoglobin [KO:K10056]
119000549  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
118978038  RARA; retinoic acid receptor alpha [KO:K08527]
118974983  LOW QUALITY PROTEIN: cyclin-A2-like [KO:K06627]
118994860  CCNA1; cyclin-A1 [KO:K06627]
118995492  CCNA2; cyclin-A2 [KO:K06627]
118987769  PML; LOW QUALITY PROTEIN: protein PML [KO:K10054] [EC:2.3.2.-]
118983269  RUNX1; runt-related transcription factor 1 isoform X1 [KO:K08367]
118995555  RUNX1T1; protein CBFA2T1 isoform X1 [KO:K10053]
118974517  SPI1; transcription factor PU.1 isoform X1 [KO:K09438]
118976331  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
118974340  CSF2RA; granulocyte-macrophage colony-stimulating factor receptor subunit alpha isoform X1 [KO:K05066]
118974345  granulocyte-macrophage colony-stimulating factor receptor subunit alpha-like [KO:K05066]
118977656  CSF3R; granulocyte colony-stimulating factor receptor isoform X1 [KO:K05061]
118986159  CSF1R; macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
118984061  CDKN2A; cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
118985966  E2F1; transcription factor E2F1 [KO:K17454]
118977797  E2F2; transcription factor E2F2 [KO:K09389]
118981164  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
118976606  MAX; protein max isoform X1 [KO:K04453]
118986310  ZBTB17; zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
118984060  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
119000945  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
118999952  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
118991404  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
118990181  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
118984889  cyclin-dependent kinases regulatory subunit 1-like [KO:K02219]
118978971  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
118990085  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
118979473  CUL1; cullin-1 [KO:K03347]
119002280  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
118998776  SKP2; S-phase kinase-associated protein 2 isoform X1 [KO:K03875]
118975970  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
119001171  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
118995572  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
118983966  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
118984458  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
118984673  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
118978970  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
118991499  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
118974481  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
118977345  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
118998656  TERT; telomerase reverse transcriptase isoform X1 [KO:K11126] [EC:2.7.7.49]
118983436  MITF; microphthalmia-associated transcription factor isoform X1 [KO:K09455]
118982068  TGFB1; transforming growth factor beta-1 proprotein [KO:K13375]
119003169  TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
118976756  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
118979591  TGFBR1; TGF-beta receptor type-1 [KO:K04674] [EC:2.7.11.30]
119004086  TGFBR2; TGF-beta receptor type-2 [KO:K04388] [EC:2.7.11.30]
118978461  SMAD2; mothers against decapentaplegic homolog 2 [KO:K04500]
118992343  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
118978766  SMAD4; mothers against decapentaplegic homolog 4 [KO:K04501]
118987426  MECOM; histone-lysine N-methyltransferase MECOM isoform X1 [KO:K04462] [EC:2.1.1.367]
118990545  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
118992930  CUNH2orf92; LOW QUALITY PROTEIN: uncharacterized protein C2orf92 homolog [KO:K04496] [EC:1.1.1.428]
118987907  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
118997724  HDAC1; histone deacetylase 1 isoform X1 [KO:K06067] [EC:3.5.1.98]
119000192  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
119004021  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
119001326  MSH2; DNA mismatch repair protein Msh2 isoform X1 [KO:K08735]
118977516  MSH3; DNA mismatch repair protein Msh3 [KO:K08736]
118988362  MSH6; DNA mismatch repair protein Msh6 isoform X1 [KO:K08737]
118980526  BRCA2; breast cancer type 2 susceptibility protein isoform X1 [KO:K08775]
118993580  RAD51; DNA repair protein RAD51 homolog 1 isoform X1 [KO:K04482]
118979183  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
118987956  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
118998399  FADD; FAS-associated death domain protein [KO:K02373]
118985238  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
118995133  BID; BH3-interacting domain death agonist [KO:K04726]
118979233  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
118996119  BBC3; bcl-2-binding component 3 isoform X1 [KO:K10132]
118994170  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
118983604  cytochrome c [KO:K08738]
119001286  cytochrome c-like [KO:K08738]
118985954  cytochrome c-like [KO:K08738]
119002556  APAF1; apoptotic protease-activating factor 1 [KO:K02084]
118999405  CASP7; caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
118985665  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
119002348  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
118983795  NQO1; NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
118981945  GSTM3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
118999438  GSTO2; glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
118999439  GSTO1; glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
118976096  glutathione S-transferase A4-like [KO:K00799] [EC:2.5.1.18]
118999851  LOW QUALITY PROTEIN: glutathione S-transferase omega-1-like [KO:K00799] [EC:2.5.1.18]
118992851  glutathione S-transferase A2-like [KO:K00799] [EC:2.5.1.18]
118992855  glutathione S-transferase alpha-4-like [KO:K00799] [EC:2.5.1.18]
118992865  glutathione S-transferase A4 [KO:K00799] [EC:2.5.1.18]
119001783  glutathione S-transferase theta-2B-like [KO:K00799] [EC:2.5.1.18]
119001784  glutathione S-transferase theta-3-like isoform X1 [KO:K00799] [EC:2.5.1.18]
119001785  glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
119001872  glutathione S-transferase theta-1-like [KO:K00799] [EC:2.5.1.18]
118978364  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
118979267  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
118995270  MGST2; microsomal glutathione S-transferase 2 isoform X1 [KO:K00799] [EC:2.5.1.18]
118991827  GSTP1; glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
119001855  TXNRD2; thioredoxin reductase 2, mitochondrial isoform X1 [KO:K22182] [EC:1.8.1.9]
118978548  TXNRD3; thioredoxin reductase 3 isoform X1 [KO:K22182] [EC:1.8.1.9]
119002544  TXNRD1; thioredoxin reductase 1, cytoplasmic isoform X1 [KO:K22182] [EC:1.8.1.9]
118993333  von Hippel-Lindau disease tumor suppressor-like [KO:K03871]
118993334  VHL; von Hippel-Lindau disease tumor suppressor [KO:K03871]
118982580  ELOC; elongin-C [KO:K03872]
118985734  elongin-C-like [KO:K03872]
118985104  ELOB; elongin-B [KO:K03873]
118982722  CUL2; cullin-2 [KO:K03870]
118996702  EGLN1; egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
118989914  EGLN3; prolyl hydroxylase EGLN3 [KO:K09592] [EC:1.14.11.29]
118984215  EGLN2; prolyl hydroxylase EGLN2 [KO:K09592] [EC:1.14.11.29]
119003173  FH; fumarate hydratase, mitochondrial isoform X1 [KO:K01679] [EC:4.2.1.2]
118976966  HIF1A; hypoxia-inducible factor 1-alpha [KO:K08268]
119001243  EPAS1; endothelial PAS domain-containing protein 1 [KO:K09095]
118991887  aryl hydrocarbon receptor nuclear translocator 2 isoform X1 [KO:K15589]
118975816  CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
119002487  EP300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
118977686  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
118990860  JAG1; protein jagged-1 [KO:K06052]
118988538  JAG2; protein jagged-2 isoform X1 [KO:K21635]
119000213  DLL1; delta-like protein 1 [KO:K06051]
118993567  DLL4; delta-like protein 4 [KO:K06051]
118988098  DLL3; delta-like protein 3 [KO:K06051]
118980064  NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599]
118981898  NOTCH2; neurogenic locus notch homolog protein 2 [KO:K20994]
118993425  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
118991536  NOTCH4; LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 4 [KO:K20996]
118982930  HES1; transcription factor HES-1 [KO:K06054]
118998172  HES5; transcription factor HES-5 [KO:K06055]
118977618  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein isoform X1 [KO:K09091]
118986727  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 isoform X1 [KO:K09091]
118995107  FLT4; vascular endothelial growth factor receptor 3 isoform X1 [KO:K05097] [EC:2.7.10.1]
118989379  SHH; sonic hedgehog protein [KO:K11988]
118993710  PTCH1; protein patched homolog 1 isoform X1 [KO:K06225]
118989161  SMO; smoothened homolog [KO:K06226]
118991971  KIF7; kinesin-like protein KIF7 isoform X1 [KO:K18806]
118999468  SUFU; suppressor of fused homolog isoform X1 [KO:K06229]
118975957  GLI1; zinc finger protein GLI1 [KO:K16797]
118989532  GLI2; zinc finger protein GLI2 [KO:K16798]
118990873  BMP2; bone morphogenetic protein 2 [KO:K21283]
118992410  BMP4; bone morphogenetic protein 4 isoform X1 [KO:K04662]
118995429  hedgehog-interacting protein [KO:K06231]
119003353  PTCH2; protein patched homolog 2 isoform X1 [KO:K11101]
118992916  AR; androgen receptor [KO:K08557]
118979369  androgen receptor-like isoform X1 [KO:K08557]
118976656  HSP90AA1; heat shock protein HSP 90-alpha [KO:K04079]
118992148  HSP90AB1; heat shock protein HSP 90-beta [KO:K04079]
118994516  endoplasmin [KO:K09487]
119002183  HSP90B1; endoplasmin [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
shon03320  PPAR signaling pathway
shon04010  MAPK signaling pathway
shon04020  Calcium signaling pathway
shon04024  cAMP signaling pathway
shon04060  Cytokine-cytokine receptor interaction
shon04066  HIF-1 signaling pathway
shon04110  Cell cycle
shon04115  p53 signaling pathway
shon04150  mTOR signaling pathway
shon04151  PI3K-Akt signaling pathway
shon04210  Apoptosis
shon04310  Wnt signaling pathway
shon04330  Notch signaling pathway
shon04340  Hedgehog signaling pathway
shon04350  TGF-beta signaling pathway
shon04370  VEGF signaling pathway
shon04510  Focal adhesion
shon04512  ECM-receptor interaction
shon04520  Adherens junction
shon04630  JAK-STAT signaling pathway
shon04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system